These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9668312)

  • 1. An autoimmune animal model of the Lambert-Eaton syndrome.
    Kim YI; Middlekauff EH; Viglione MP; Okutsu J; Satoh Y; Hirashima N; Kirino Y
    Ann N Y Acad Sci; 1998 May; 841():670-6. PubMed ID: 9668312
    [No Abstract]   [Full Text] [Related]  

  • 2. Rats immunized with cholinergic synaptosomes: a model for Lambert-Eaton syndrome.
    Chapman J; Rabinowitz R; Korczyn AD; Michaelson DM
    Muscle Nerve; 1990 Aug; 13(8):726-33. PubMed ID: 2385259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
    Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
    Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
    Flink MT; Atchison WD
    J Physiol; 2002 Sep; 543(Pt 2):567-76. PubMed ID: 12205190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive nerve stimulation in studies of respiratory involvement in myasthenia gravis.
    Zifko U; Bolton CB; Nicolle MW
    Ann N Y Acad Sci; 1998 May; 841():716-9. PubMed ID: 9668319
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of myasthenia gravis and Lambert-Eaton syndrome.
    Maselli RA
    Neurol Clin; 1994 May; 12(2):285-303. PubMed ID: 8041343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative evaluation of the status of neuromuscular transmission and evoked skin sympathetic potential in myasthenia syndrome of the Eaton-Lambert type in patients with and without bronchogenic carcinoma].
    Bzhilianskiĭ MA; Sanadze AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):21-5. PubMed ID: 2176034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
    Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
    Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lambert-Eaton myasthenic syndrome.
    Irita K; Satoh M; Akata T; Yano T; Takahashi S; Yoshitake J
    Can J Anaesth; 1990 Nov; 37(8):944. PubMed ID: 2174748
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of cadmium-induced blockade of neuromuscular transmission.
    Satoh E; Asai F; Itoh K; Nishimura M; Urakawa N
    Eur J Pharmacol; 1982 Feb; 77(4):251-7. PubMed ID: 6277669
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenic sites of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome.
    Takamori M; Iwasa K; Komai K
    Ann N Y Acad Sci; 1998 May; 841():625-35. PubMed ID: 9668306
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome.
    Chaudhry V; Watson DF; Bird SJ; Cornblath DR
    Muscle Nerve; 1991 Dec; 14(12):1227-30. PubMed ID: 1662773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP, transmitter release and the effect of adenosine on neuromuscular transmission.
    Ginsborg BL; Hirst GD
    Nat New Biol; 1971 Jul; 232(28):63-4. PubMed ID: 4327745
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophysiologic tests of neuromuscular transmission.
    Sanders DB
    Suppl Clin Neurophysiol; 2004; 57():167-9. PubMed ID: 16106617
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lambert-Eaton myasthenic syndrome and myasthenia gravis].
    Takamori M; Iwasa K; Komai K; Yasukawa Y
    No To Shinkei; 1997 Dec; 49(12):1089-100. PubMed ID: 9453039
    [No Abstract]   [Full Text] [Related]  

  • 19. Lambert-Eaton myasthenic syndrome in children.
    Tsao CY; Mendell JR; Friemer ML; Kissel JT
    J Child Neurol; 2002 Jan; 17(1):74-6. PubMed ID: 11913581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic adaptation in diseases of the neuromuscular junction.
    Molenaar PC
    Prog Brain Res; 1990; 84():145-9. PubMed ID: 2267292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.